Shakespeare and business. Yoking together these two words seems almost surreal. Yet on April 15, Washington University’s Olin Business School — under the aegis of its dean, Mark P. Taylor — did something which would be unimaginable anywhere else in the United States.
Apologies only go so far. As #MeToo reminds us, we must look beyond the “bad man.” We must confront the systems that enable sexual violence — systems that all too often we countenance with our own participation.
Two new documentaries, released within months of each other, reveal just how much Kennedy and Rogers share in common: Dawn Porter’s “Bobby Kennedy for President”, on Netflix since April, and Morgan Neville’s “Won’t You Be My Neighbor?”, in theatres June 8, two days after the fiftieth anniversary of RFK’s assassination.
What’s it going to take for us to recognize the value of cannabis in combating the opioid epidemic? Medical professionals and scientists do not need additional convincing. But others certainly do. As a nation, we must acknowledge cannabis as the exit drug to the opioid epidemic.
Overall, budgets and staffing levels at regulatory agencies have been increasing over the last six decades. Whether Trump’s deregulatory emphasis will have an impact on the size of the regulatory agencies remains to be seen.